Cyril Camaro, Department of Cardiology, theme Vascular damage, received a ZonMw grant of EUR 450k for a study of patients suspected of acute coronary syndrome (ACS).The ARTICA study (“Acute Rule out of non ST-segment elevation acute coronary syndrome in the (pre)hospital setting bye HEART score assessment and a single point of care Troponin”) is a multicenter randomized trial to assess the cost-effectiveness and efficacy of ambulance triage with further general practitioner management compared to standard hospital admission in patients with symptoms suggestive for non-ST elevation ACS, but with low risk characteristics (low HEART score and negative troponin). This study will be executed in strong partnership with our networkpartner CWZ and local Ambulance Services.
Cyril Camaro is interventional cardiologist / academic researcher and member theme Vascular damage.
Related news items
Radboud Pluim for Lionne Ekers ambassador for the RIMLS institute30 June 2020
Lionne Ekers received the Radboudpluim for her special merits for the Radboudumc. She is a born ambassador for our Institute.read more
Stefan Listl member of the new Lancet Commission on Oral Health29 June 2020
In recognition of the global public health importance, woeful neglect of oral diseases, and the need for a broader understanding and commitment to global oral health within medicine and global health agendas, The Lancet recently established a Commission on Oral Health.read more
Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection29 June 2020
In a review in Cell Mihai Netea, Frank van de Veerdonk, Reinout van Crevel and Jorge Dominguez Andres propose that induction of trained immunity by whole-microorganism vaccines may represent an important tool for reducing susceptibility to and severity of SARS-CoV-2.read more
UMD Catalist grant for Mohammad Alsady and Federica Conte24 June 2020
They received this award to explore the potential of hiPS-derived skeletal muscle cells as model to investigate muscular pathophysiologic mechanisms in phosphoglucomutase I deficiency.read more